Search filters

List of works by Kateřina Mičová

A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment

scientific article published on 22 June 2015

Detailed study of imatinib metabolization using high-resolution mass spectrometry

scientific article published on 13 July 2015

Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine

scientific article published on January 2016

Flow injection analysis vs. ultra high performance liquid chromatography coupled with tandem mass spectrometry for determination of imatinib in human plasma.

scientific article published on 13 August 2010

Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher pla

scientific article published in May 2010

Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting

scientific article published on 11 January 2012

Isotope dilution direct injection mass spectrometry method for determination of four tyrosine kinase inhibitors in human plasma.

scientific article

Metabolic status of CSF distinguishes rats with tauopathy from controls.

scientific article published on 21 September 2017

Metabolite Profiling of the Plasma and Leukocytes of Chronic Myeloid Leukemia Patients

scientific article published on 28 July 2016

Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis.

scientific article published on 19 April 2017

Ultrafast Online SPE-MS/MS Method for Quantification of 3 Tyrosine Kinase Inhibitors in Human Plasma.

scientific article published in August 2016

Paulina is supported by:

About Paulina

Help